CIMS Adds Clinical Trial Design Expert to the Team

CIMS Global, the pioneer of dynamic trial design (DTD) and dynamic data monitoring (DDM), has added another clinical trial expert to its advisory board.

Kuang-Kuo Gordon Lan will serve as a Sr. Advisor and received his PhD in Mathematical Statistics (1974) from Columbia University and is serving as CIMS Senior Statistical Advisor. Dr. Lan has published over 70 research papers on statistical methods in medical research and has given over 230 invited talks at universities and professional meetings worldwide. His most notable contribution is the development, with Dr. David DeMets, of the alpha spending approach to the design and interim analysis of clinical trials. He is also a co-author (with Drs. Mike Proschan and Janet Wittes) of the guiding book titled “Statistical Monitoring of Clinical Trials: A Unified Approach,” which is widely used by industry and academia as a textbook in clinical trial design. Gordon was elected Fellow of the American Statistical Association in 1992, and Fellow of the Society of Clinical Trials in 2009.

CIMS was founded by Dr. Tai Xie, an industry pioneer focused on reshaping the future of clinical trials through the convergence of EDC and IWRS, statistical modeling and machine learning.

Contact us to learn more about how CIMS’ DDM and DTD allows sponsors to dynamically monitor and optimize their clinical trials — overcoming the drawbacks of classical adaptive group sequential designs to dynamically monitor trials without using an Independent Statistical Group (ISG) and/or Independent Data Monitoring Committee (IDMC).






Leave a Reply

Your email address will not be published. Required fields are marked *